We are live on ! Find out more
AEMD icon

Aethlon Medical

6 hedge funds and large institutions have $61K invested in Aethlon Medical in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

20% more funds holding

Funds holding: 56 (+1)

0% more ownership

Funds ownership: 0%0% (+0%)

67% less capital invested

Capital invested by funds: $185K → $61K (-$124K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q4 2019 in Review

6 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2019, worth a combined $61K — down 67% from $185K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AEMD positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $71.7K. The largest seller was Geode Capital Management, exiting entirely with an estimated $29K sold.

  • 6 institutional investors held Aethlon Medical (AEMD) as of Q4 2019, up from 5 in Q3 2019.
  • Funds reported $61K of Aethlon Medical stock for Q4 2019, down 67% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q4 2019 and 2 closed out, a net change of +1 holder.
  • The largest Aethlon Medical buyer in Q4 2019 was Renaissance Technologies, an estimated $71.7K added.
  • The largest Aethlon Medical seller in Q4 2019 was Geode Capital Management, an estimated $29K sold.

Based on aggregated 13F filings for Q4 2019.